Bram Industries in Q1: Packaging Profit Returns and the New Deal Carries a NIS 58 Million Guarantee
Bram Industries opened 2026 with NIS 1.5 million of operating profit after a sharp rebound in food-packaging profitability. The next quarter will already absorb higher raw-material costs, while an unclosed plastic-injection deal adds industrial optionality alongside a bank guarantee that is large relative to the company's scale.
The first quarter at Bram Industries shows a real operating turn and leaves two proof points open. Food-packaging segment results moved from a loss to a NIS 1.8 million profit, consolidated gross margin rose to 28.9%, and profit from continuing operations reached NIS 673 thousand after a NIS 730 thousand loss in the comparable quarter. The improvement came from recovering demand, automation and lower real raw-material costs at the start of the period. Near the end of the quarter and after it, the setup changed: raw materials and other production inputs rose by more than 50%, customer price increases began only in April 2026 and were partial, and the company already expects more significant margin erosion in the second quarter. A deal to acquire 50% of a private plastic-injection company is still subject to closing conditions, yet includes a commitment by a consolidated company to provide, jointly with the seller, a guarantee for bank debt of about NIS 58 million. The current read combines genuine operating recovery, pricing that still has to pass through to customers, and a financing-risk layer that may be much larger than the direct purchase price.
Food Packaging Carries Almost All of Bram's Economics
The company operates through investees in the development, production and marketing of injection-molded plastic products, mainly packaging for the food industry, alongside unique home products and a young electrical-testing products activity. Its plants are in Sderot and near Netivot. The business model is industrial: production volume, raw-material prices, line utilization, customer credit, inventory and investment funding decide profit and cash.
The segment data gives a sharper map than the formal business description. Of NIS 15.3 million in segment revenue in the quarter, NIS 15.25 million came from food-industry packaging. Home products contributed only NIS 9 thousand of revenue and a NIS 187 thousand segment loss, and the other activity contributed NIS 40 thousand of revenue and a NIS 120 thousand loss. After Bramli USA was classified as discontinued activity, the smaller layers still subtract slightly from profit. Packaging carries almost the entire thesis.
The joint venture Preform Beverages adds an important layer to packaging, even though it does not enter the ordinary consolidated revenue line. Preform produces plastic preforms and caps for the beverages market, and its revenue rose to NIS 3.3 million from NIS 2 million in the comparable quarter. Its loss narrowed to NIS 158 thousand from NIS 450 thousand, and Bram's share of the loss fell to NIS 79 thousand. That is business progress, not full profitability. Preform's own operating cash flow was negative NIS 398 thousand, mainly because customers, receivables and inventory rose. In other words, its income-statement improvement still has to pass through collection and inventory before it becomes a cash source.
First-Quarter Profitability Was Built Before the Input-Cost Shock
Consolidated operating profit reached NIS 1.54 million versus a NIS 650 thousand operating loss in the comparable quarter. Revenue rose only 4.8% to NIS 13.7 million, so most of the change came from the cost line: cost of sales fell 15%, and gross profit jumped to NIS 4 million. A 28.9% gross margin looks unusually strong compared with 12.3% in the comparable quarter and 17.6% in full-year 2025.
The operating explanation matters. Packaging benefited from higher demand, greater production output, new product launches, improvements to existing products, automation and technological upgrades in the production system. This was not merely an accounting rebound after a weak year. It was an improvement in utilization and in the cost structure of the core activity.
The issue is timing. Near quarter-end and afterward, following Operation Shagat HaAri and the closure of the Strait of Hormuz, the main raw material and other inputs became sharply more expensive. The company updated prices for all customers in April 2026 at a level that does not cover the full input-cost increase. The first quarter therefore proves that the business can be profitable when raw materials are favorable and production lines run more efficiently. The second quarter will show whether customers can absorb enough of the new pricing.
There is a possible offset: after the quarter ended, the dollar and euro fell against the shekel by about 10% and 9% through shortly before the financial statements were approved. Because the company's raw materials are dollar-denominated or dollar-linked, the weaker dollar may support profitability. That does not cancel the operating warning. It only makes the second-quarter read less one-directional: oil and input prices create pressure, the dollar can help, and the spread between purchase costs and customer prices will set the margin.
Investments, Repayments and New Funding Absorbed Operating Cash Flow
Operating cash flow was NIS 243 thousand, compared with negative NIS 720 thousand in the comparable quarter. That number is far narrower than operating profit and the NIS 3.36 million of segment EBITDA. The main reason is balance-sheet timing: receivables rose by NIS 1.6 million, inventory rose by NIS 375 thousand, and payables fell by NIS 689 thousand after payments to raw-material suppliers that had been deferred in the prior year. In a manufacturing company, profit has to be tested through customers, inventory and suppliers, not only through gross margin.
The company says average customer credit is more than 90 days. That is not necessarily abnormal for an industrial company selling to retailers and wholesalers. In a quarter of higher output, that same credit increases the funding need. Higher revenue can lift profit while pulling cash into receivables until collection arrives.
All-in cash flexibility after actual cash uses is tighter than the headline of positive operating cash flow. After NIS 243 thousand from operations, the company invested NIS 1.09 million in property and equipment, repaid NIS 1.38 million of long-term loans and other liabilities, and paid NIS 481 thousand of lease liabilities. It received a NIS 3 million long-term loan, for six years and at prime-plus interest, to fund its investment plan. Cash rose to NIS 3.8 million mainly through new financing, not through free cash surplus.
The Netivot investment is the important capital movement. During the quarter, the company invested about NIS 1.1 million in cash, mainly in infrastructure at the Netivot site, automation and product renewal. In addition, it recorded NIS 5.9 million of non-cash additions to property, equipment and right-of-use assets through supplier credit and leases. The company is building capacity and infrastructure, including the start of kraft product manufacturing, while increasing the lease and liability layer around the new site. For the investment to work, the new products need to convert into sales and collection at a pace that covers repayments and leases.
The Injection Deal Moves the Next Read to Pricing, Collection and Bank Terms
The most material event outside the operating quarter is the February 17, 2026 agreement to acquire 50% of a private plastic-injection company that serves defense, medical, automotive and advanced packaging markets. The direct consideration is NIS 2.5 million, and the deal had not closed when the statements were approved.
The purchase price alone can be misleading. The consolidated company is expected to provide, jointly and severally with the seller, a guarantee for the target company's bank debts of about NIS 58 million. With a late-May market capitalization of about NIS 29 million, NIS 45.9 million of equity and NIS 3.8 million of cash, the guarantee is a separate risk layer.
The closing conditions include third-party and bank approvals, amendments to the target company's bank covenants, and a new management agreement with the seller. The parties extended the closing deadline to June 7, 2026. The deal can expand the injection-molding platform, and it depends on bank consent and covenant repair at the target.
The first quarter improves the starting point: food packaging generated profit and Preform narrowed its loss. The next read depends on second-quarter margin after the price update, collection from customers with average credit of more than 90 days, and the bank terms attached to the injection deal. Holding margin, stable collection and a deal closing without unusual risk expansion would make Q1 look like the start of a repair. Insufficient pricing and an active guarantee before profitability stabilizes would leave the quarter as a starting point, not full proof.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.